[網路] Goolge Reader Collection 26/12/2010

ACLS常用藥物 2010年更新版 (ACLS Core Drugs: An Update)...

來自 the New England Journal of Stupid Jerry Liu 著

Ashampoo 送你五套正版軟體免費下載，五個願望一次滿足！

來自 免費資源網路社群 Pseric 著

我的 Firefox 攻略

來自 電腦玩物 異塵行者 著

AddThis - Share & Bookmark (new) - Google 瀏覽器擴充功能庫

來自 chrome.google.com

What 3.0: [PC Game] Torchlight - 火炬之光

來自 what30.blogspot.com

六個人的小世界 討論網路時代人際關係的經典概念

來自 twhsi的BLOG

Dropbox 1.0 正式發佈！世界上最好的雲端同步軟體邁進新里程

來自 電腦玩物 異塵行者 著

[網路] my Android: iHugo.Android

用 Androidify 做成的個人Android 圖像！有像我嘛？ 這個可是經過阿梓梓調整過的版本！
可以參考：Androidify 打造個性化Android公仔，幫每個聯絡人自訂虛擬人物。

[網路] 2011/2 Google reader收藏集

2011年二月份就快要過去了！來回顧一下這個月份的 Google Reader @iHugo有什麼收藏吧！

網路資訊類：
[android app] Androidify 凝聚力最強、趣味又高的軟體
Acer ICONIA：14吋雙螢幕觸控筆電上市
Google Reader App widget 搭個人資訊牆善用手機零碎閱讀時間

利用 Dropbox 與朋友分享資料

四大 平板電腦 集合，你選哪一個？

 

醫學資訊類
Sarcoidosis(JAMA)

活化蛋白C到底該怎麼用? (Clinical Use of Activated Protein C)

H1N1 使用類固醇可能有害！

EUS教學(8)急診超音波在深部靜脈栓塞之應用

美國醫師學會住院患者血糖控制指引 (ACP Clinical Practice Guidelines: Use of Intensive Insulin Therapy in Hospitalized Patients)...

SocialGmail 強化Gmail社交！在郵件中顯示來信好友的大頭照片

醫療相關的RSS (Medical RSS)...

學習成長類
隨時讚美與關懷他人，讓好感度直上升
失去「顧客的資料」跟失去「顧客」那個損失比較大？
RD 如何養成 寫筆記 / 製作 SOP 的習慣

 

大家參考一下吧！

[醫學] Clinicopathological characteristics of patients wi... [Kidney Int. 2010] - PubMed result

最近見到了一個的 G4-related tubulointerstitial nephritis

正巧前幾個月在KI有篇 review跟大家分享一下

Clinicopathological characteristics of patients wi... [Kidney Int. 2010] - PubMed result

Kidney Int. 2010 Nov;78(10):1016-23. Epub 2010 Aug 18.

Clinicopathological characteristics of patients with IgG4-related tubulointerstitial nephritis.

Saeki T, Nishi S, Imai N, Ito T, Yamazaki H, Kawano M, Yamamoto M, Takahashi H, Matsui S, Nakada S, Origuchi T, Hirabayashi A, Homma N, Tsubata Y, Takata T, Wada Y, Saito A, Fukase S, Ishioka K,Miyazaki K, Masaki Y, Umehara H, Sugai S, Narita I.

Department of Internal Medicine, Nagaoka Red Cross Hospital, Nagaoka, Niigata, Japan. saekit@nagaoka.jrc.or.jp

Comment in:

• Kidney Int. 2010 Nov;78(10):951-3.

Abstract

IgG4-related disease is a recently recognized multi-organ disorder characterized by high levels of serum IgG4 and dense infiltration of IgG4-positive cells into several organs. Although the pancreas was the first organ recognized to be affected by IgG4-related disorder in the syndrome of autoimmune pancreatitis, we present here clinico-pathological features of 23 patients diagnosed as having renal parenchymal lesions. These injuries were associated with a high level of serum IgG4 and abundant IgG4-positive plasma cell infiltration into the renal interstitium with fibrosis. In all patients, tubulointerstitial nephritis was the major finding. Although 14 of the 23 patients did not have any pancreatic lesions, their clinicopathological features were quite uniform and similar to those shown in autoimmune pancreatitis. These included predominance in middle-aged to elderly men, frequent association with IgG4-related conditions in other organs, high levels of serum IgG and IgG4, a high frequency of hypocomplementemia, a high serum IgE level, a patchy and diffuse lesion distribution, a swirling fibrosis in the renal pathology, and a good response to corticosteroids. Thus, we suggest that renal parenchymal lesions actually develop in association with IgG4-related disease, for which we propose the term 'IgG4-related tubulointerstitial nephritis.'

PMID: 20720530 [PubMed - in process]

[醫學] 轉載: Tamoxifen is associated with lower mortality of en... [Nephrol Dial Transplant. 2011] - PubMed result

Tamoxifen is associated with lower mortality of en... [Nephrol Dial Transplant. 2011] - PubMed result

Nephrol Dial Transplant. 2011 Feb;26(2):691-697. Epub 2010 Jun 27.

Tamoxifen is associated with lower mortality of encapsulating peritoneal sclerosis: results of the Dutch Multicentre EPS Study.

Korte MR, Fieren MW, Sampimon DE, Lingsma HF, Weimar W, Betjes MG; on behalf of the investigators of the Dutch Multicentre EPS Study.

Correspondence and reprint requests to: Mario R. Korte; E-mail: m.r.korte@asz.nl.

Abstract

BACKGROUND: Encapsulating peritoneal sclerosis (EPS) is a serious complication of peritoneal dialysis (PD) with an increasing incidence. There is no clear consensus on the treatment of EPS, but anecdotal reports indicate improvement in EPS patients treated with tamoxifen. At present, there is no evidence for the effect of tamoxifen treatment in EPS patients. This study investigates the effect of treatment with tamoxifen on survival in EPS patients.

METHODS: This study is a retrospective analysis of survival in EPS patients as part of the Dutch multicentre EPS study in the period January 1996 to July 2007. Sixty-three patients with severe EPS were followed up until August 2008. Demographic, patient and PD-related variables of EPS patients were investigated. Patients treated with tamoxifen were compared to patients not treated with tamoxifen. Survival was analysed with multivariate Cox regression analysis.

RESULTS: Twenty-four patients were treated with tamoxifen, and 39 were not treated with tamoxifen. The clinical and demographic characteristics were similar for the tamoxifen-treated and non-treated groups. The mortality rate was significantly lower in tamoxifen-treated patients compared to EPS patients not treated with tamoxifen (45.8% vs 74.4%, P = 0.03). Survival in tamoxifen-treated patients, adjusted for calendar time, age, use of corticosteroids, presence of functioning transplantation, use of parental nutrition and centre influences was longer in comparison to not-treated patients (HR 0.39, P = 0.056).

CONCLUSIONS: Tamoxifen treatment in EPS patients is associated with lower mortality and shows a trend to an increased multivariate-adjusted survival. This supports additional use of tamoxifen to treat patients with severe EPS.

PMID: 20584735 [PubMed - as supplied by publisher]